MedPath

CHILDREN'S HOSPITAL OF PHILADELPHIA

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
1855-01-01
Employees
-
Market Cap
-
Website
http://www.chop.edu/

Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma

Phase 1
Terminated
Conditions
Leukemia
Lymphoma
Interventions
First Posted Date
2003-09-11
Last Posted Date
2015-03-12
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
10
Registration Number
NCT00068302
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma

Not Applicable
Terminated
Conditions
Neurofibromatosis Type 1
Precancerous Condition
Interventions
Radiation: fludeoxyglucose F 18
Radiation: gadopentetate dimeglumine
First Posted Date
2003-05-07
Last Posted Date
2014-04-04
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
18
Registration Number
NCT00060008
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas

Phase 2
Completed
Conditions
Neurofibromatosis Type 1
Precancerous Condition
Interventions
First Posted Date
2003-01-27
Last Posted Date
2018-08-08
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
23
Registration Number
NCT00030264
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma

Phase 2
Terminated
Conditions
Brain Tumors
Central Nervous System Tumors
Medulloblastoma
Interventions
First Posted Date
2003-01-27
Last Posted Date
2019-04-25
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
30
Registration Number
NCT00031590
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Lucile Packard Children's Hospital at Stanford University Medical Center, Palo Alto, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Winship Cancer Institute of Emory University, Atlanta, Georgia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma

Phase 1
Terminated
Conditions
Brain and Central Nervous System Tumors
First Posted Date
2003-01-27
Last Posted Date
2015-03-19
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
11
Registration Number
NCT00031577
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Winship Cancer Institute of Emory University, Egleston, Georgia, United States

Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis)

Phase 1
Completed
Conditions
Cystic Fibrosis
Interventions
Drug: Sodium 4-Phenylbutyrate (4PBA)
Drug: Unconjugated Isoflavones 100 (PTI G-4660, 87% Genistein)
Drug: Placebo
First Posted Date
2001-06-04
Last Posted Date
2009-01-09
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
12
Registration Number
NCT00016744

Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

Not Applicable
Completed
Conditions
Hyperinsulinism
First Posted Date
2000-02-25
Last Posted Date
2015-03-25
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
8
Registration Number
NCT00004699

Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

Phase 2
Completed
Conditions
Hyperinsulinism
First Posted Date
2000-02-25
Last Posted Date
2015-03-25
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
16
Registration Number
NCT00004700
ยฉ Copyright 2025. All Rights Reserved by MedPath